Lamotrigine Eg

Lamotrigine, the active ingredient in Lamotrigine Eg, is an anticonvulsant presented as a tablet for oral use. It treats epilepsy and bipolar disorder in adults and children as prescribed.

GNH USA supplies Lamotrigine Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used to manage seizure disorders and mood stabilization in bipolar disorder.

Epilepsy: reduces the frequency and severity of seizures. Bipolar disorder: helps maintain mood stability and prevents depressive episodes. Adjunct therapy for seizure disorders: can be combined with other antiepileptic drugs to improve seizure control.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Headache - Nausea or vomiting - Blurred vision - Insomnia - Skin rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., exfoliative dermatitis) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior - Aseptic meningitis

When prescribing lamotrigine, clinicians should consider several safety measures.

Monitor blood counts: watch for signs of agranulocytosis or other hematologic abnormalities. Assess liver function: adjust dosing in patients with hepatic impairment. Adjust dose in renal impairment: renal dysfunction may require dose modification. Pregnancy caution: risk category is unknown; use only if benefits outweigh risks. Avoid abrupt discontinuation: taper gradually to reduce seizure recurrence. Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma levels.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations, raising toxicity risk. - Carbamazepine: significantly reduces lamotrigine levels, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine concentrations, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating monitoring of seizure control. - Rifampin: induces metabolism and can reduce lamotrigine exposure. - Serotonergic agents: concurrent use may increase the risk of serotonin‑related adverse effects.